- Home
- VCYT vs CLM Comparison
VCYT vs CLM Comparison
Compare VCYT & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VCYT | CLM |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VCYT | CLM |
|---|---|---|
| Price | $32.95 | $7.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $45.13 | N/A |
| AVG Volume (30 Days) | 802.9K | ★ 2.8M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $12.53 | N/A |
| P/E Ratio | $41.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.61 | $6.57 |
| 52 Week High | $50.71 | $8.53 |
Technical Indicators
Market Signals| Indicator | VCYT | CLM |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 41.32 |
| Support Level | $32.51 | $7.05 |
| Resistance Level | $32.79 | $8.29 |
| Average True Range (ATR) | 1.45 | 0.21 |
| MACD | -0.16 | -0.00 |
| Stochastic Oscillator | 0.42 | 55.56 |
Price Performance
Historical ComparisonAbout VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.